David Mauro

David Mauro

Chief Medical OfficeratRecursion Pharmaceuticals· In proxies 2023–2024

Pay in FY2024-55% from the year before · Recursion Pharmaceuticals stock -31.4% the same year

David Mauro was paid $1.9M in FY2024 (Dec), down 55%. Recursion Pharmaceuticals stock fell 31.4% that year.

Pay$100 in the stock at the end of FY22 → $88
Pay is from the Summary Compensation Table of each Recursion Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Recursion PharmaceuticalsPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?